H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
H. 限制宿主反应的幽门螺杆菌特异性调节 T 细胞
基本信息
- 批准号:7343179
- 负责人:
- 金额:$ 17.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimalsBacteriaBiological AssayBypassC57BL/6 MouseCD4 Positive T LymphocytesCeliac DiseaseCellsChronicClinicCoculture TechniquesColonCytokine ReceptorsDataDevelopmentDiseaseDown-RegulationEnzyme-Linked Immunosorbent AssayFlow CytometryFood HypersensitivityGastric mucosaGastritisGastrointestinal tract structureGenus ColaGenus FelisHelicobacter InfectionsHelicobacter Pylori-Associated GastritisHelicobacter pyloriHistologicHumanImmuneImmune responseImmunityImmunologicsImmunotherapyIn VitroInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInterleukin-10Intestinal MucosaKnowledgeLaboratoriesLifeLymphoid TissueModelingMucous MembraneMusNADPH OxidaseNatural ImmunityNoseNumbersOralPeptic UlcerPlayProcessPropertyPylorusRegulationRoleRouteSCID MiceSpleenSpottingsStomachSurfaceT-Cell ActivationT-LymphocyteTestingTransgenic MiceVaccinatedVaccinationVaccinesWeekWild Type Mousecytokinedesigngastrointestinalimmunoregulationmouse modelpathogenpreventreconstitutionrectalresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Helicobacter pylori (H. pylori) colonizes the human gastric mucosa and plays an etiologic role in the development of gastritis and peptic ulcer disease. Infection persists for life despite the induction of histologic gastritis and specific immune responses. Similar observations have been made in the H. pylori-mouse model. However, mice lacking either IL-10 or NADPH oxidase develop inflammation in response to H. pylori that is significantly more intense than infected wild type mice, and spontaneously clear the bacteria from the gastric mucosa. Additionally, eradication of H. pylori from immunized mice following challenge is also accompanied by more intense inflammation. Therefore, H. pylori may persist due to the inability of the host to develop sufficiently intense inflammation during infection. The induction of down-regulatory T-cells that prevent aberrant responses to noninvasive bacteria in the colon has been described. These mechanisms may be conserved along the gastrointestinal tract and may be active in the gastric mucosa. This proposal will test the hypothesis that activation of T-cells at the gastric mucosa during H. pylori infection induces IL-10 producing regulatory T cells that suppress the inflammatory response, thus allowing for persistent infection. A correlate of this hypothesis is that vaccination effectively bypasses this down-regulation by activating T-cells in lymphoid tissue where the induction of IL-10 producing T-cells is not favored. We will address this hypothesis by: 1) Characterizing surface markers and cytokine profiles of gastric T cell from infected and immune mice to distinguish regulatory T-cells from protective T-cells. Flow cytometry and ELISA spot assays will be used to examine freshly isolated T-cells. 2) Identify the factors in the gastric mucosa that contribute to the induction of these regulatory cells. Transgenic mice and co-culture models will be used to explore the relationship of specific co-receptors and cytokines to T-cell activation in the stomach. 3) Investigate how regulatory T-cells interact with other cells to down-regulate inflammation. Regulatory T-cells will be studied in mice and in vitro to define the extent of their regulatory properties. These studies will increase our understanding of gastrointestinal immunoregulation and the design of better immunotherapies.
描述(由申请人提供):幽门螺杆菌(H. pylori)定植于人类胃粘膜并在胃炎和消化性溃疡疾病的发展中发挥病因作用。尽管诱发组织学胃炎和特异性免疫反应,感染仍持续终生。 在幽门螺杆菌小鼠模型中也进行了类似的观察。然而,缺乏 IL-10 或 NADPH 氧化酶的小鼠对幽门螺杆菌产生的炎症反应明显比受感染的野生型小鼠更强烈,并自发地清除胃粘膜中的细菌。此外,在攻击后从免疫小鼠中根除幽门螺杆菌也伴随着更强烈的炎症。因此,由于宿主在感染过程中无法产生足够强烈的炎症,幽门螺杆菌可能会持续存在。诱导下调 T 细胞可防止对结肠中非侵入性细菌的异常反应。这些机制可能在胃肠道中保守,并且可能在胃粘膜中活跃。该提案将检验以下假设:幽门螺杆菌感染期间胃粘膜 T 细胞的激活会诱导产生 IL-10 的调节性 T 细胞,抑制炎症反应,从而实现持续感染。与这一假设相关的是,疫苗接种通过激活淋巴组织中的 T 细胞,有效绕过这种下调,而淋巴组织中不利于诱导产生 IL-10 的 T 细胞。 我们将通过以下方式解决这一假设:1) 表征感染小鼠和免疫小鼠胃 T 细胞的表面标记和细胞因子谱,以区分调节性 T 细胞和保护性 T 细胞。 流式细胞术和 ELISA 斑点测定将用于检查新鲜分离的 T 细胞。 2) 确定胃粘膜中有助于诱导这些调节细胞的因素。转基因小鼠和共培养模型将用于探索特定共受体和细胞因子与胃中 T 细胞激活的关系。 3) 研究调节性 T 细胞如何与其他细胞相互作用来下调炎症。调节性 T 细胞将在小鼠和体外进行研究,以确定其调节特性的程度。 这些研究将增加我们对胃肠道免疫调节的理解和更好的免疫疗法的设计。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen.
Muc1 细胞表面粘蛋白可减轻对常见粘膜病原体的上皮炎症反应。
- DOI:
- 发表时间:2010-07-02
- 期刊:
- 影响因子:0
- 作者:Guang, Wei;Ding, Hua;Czinn, Steven J;Kim, K Chul;Blanchard, Thomas G;Lillehoj, Erik P
- 通讯作者:Lillehoj, Erik P
Recent advances that favor development of a vaccine for Helicobacter pylori infection.
最近的进展有利于幽门螺杆菌感染疫苗的开发。
- DOI:
- 发表时间:2008-10-01
- 期刊:
- 影响因子:0
- 作者:Ding, Hua;Czinn, Steven J;Blanchard, Thomas G
- 通讯作者:Blanchard, Thomas G
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS G BLANCHARD其他文献
THOMAS G BLANCHARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS G BLANCHARD', 18)}}的其他基金
Pediatric Biospecimen Procurement Center (BPC) Supporting the Developmental Gene Expression (dGTEx) Project
儿科生物样本采购中心 (BPC) 支持发育基因表达 (dGTEx) 项目
- 批准号:
10311912 - 财政年份:2021
- 资助金额:
$ 17.76万 - 项目类别:
Prenatal alcohol effects on the gut microbiome contributing to failure to thrive and altered immune function
产前酒精对肠道微生物组的影响导致发育不良和免疫功能改变
- 批准号:
9391802 - 财政年份:2017
- 资助金额:
$ 17.76万 - 项目类别:
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to
肽构象约束技术和新型粘膜佐剂
- 批准号:
7701567 - 财政年份:2009
- 资助金额:
$ 17.76万 - 项目类别:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
H. 限制宿主反应的幽门螺杆菌特异性调节 T 细胞
- 批准号:
7021369 - 财政年份:2004
- 资助金额:
$ 17.76万 - 项目类别:
H. PYLORI- REGULATORY T CELLS THAT LIMIT HOST RESPONSE
H. 幽门螺杆菌——限制宿主反应的调节性 T 细胞
- 批准号:
6775044 - 财政年份:2004
- 资助金额:
$ 17.76万 - 项目类别:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
H. 限制宿主反应的幽门螺杆菌特异性调节 T 细胞
- 批准号:
6846053 - 财政年份:2004
- 资助金额:
$ 17.76万 - 项目类别:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
H. 限制宿主反应的幽门螺杆菌特异性调节 T 细胞
- 批准号:
7630113 - 财政年份:2004
- 资助金额:
$ 17.76万 - 项目类别:
H. PYLORI-SPECIFIC REGULATORY T CELLS THAT LIMIT HOST RESPONSE
H. 限制宿主反应的幽门螺杆菌特异性调节 T 细胞
- 批准号:
7173722 - 财政年份:2004
- 资助金额:
$ 17.76万 - 项目类别:
Helicobacter Pylori-Specific Regulatory T Cells that Limit the Host Response
限制宿主反应的幽门螺杆菌特异性调节 T 细胞
- 批准号:
8145397 - 财政年份:2002
- 资助金额:
$ 17.76万 - 项目类别:
Peptide Conformation Constrainment Technology and Novel Mucosal Adjuvants to
肽构象约束技术和新型粘膜佐剂
- 批准号:
8119514 - 财政年份:
- 资助金额:
$ 17.76万 - 项目类别:
相似国自然基金
哺乳动物细胞分泌的AI-2信号类似物鉴定及其在宿主-细菌相互作用中的功能研究
- 批准号:32370134
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于口腔灌注种植体周围炎动物模型探索多细菌感染后的宿主免疫反应机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
渭河潜流带无脊椎动物-细菌协同驱动的溶解有机质迁移转化机理研究
- 批准号:42101085
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
海参养殖区丝状绿潮藻、细菌和原生动物群落耦合动力学研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
病原细菌受体激酶ThrK识别动物激素信号的机制
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
相似海外基金
An Integrated Catheter Dressing for Early Detection of Catheter-related Bloodstream Infections
用于早期检测导管相关血流感染的集成导管敷料
- 批准号:
10647072 - 财政年份:2023
- 资助金额:
$ 17.76万 - 项目类别:
Postnatal and Prenatal Therapeutic Base Editing for Metabolic Diseases
代谢性疾病的产后和产前治疗碱基编辑
- 批准号:
10668614 - 财政年份:2023
- 资助金额:
$ 17.76万 - 项目类别:
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
开发一类针对碳青霉烯类耐药革兰氏阴性生物的新型肽抗生素
- 批准号:
10674131 - 财政年份:2023
- 资助金额:
$ 17.76万 - 项目类别:
Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
志贺氏菌结合疫苗 (SCV4) 的开发、表征和临床前评估
- 批准号:
10704325 - 财政年份:2023
- 资助金额:
$ 17.76万 - 项目类别:
2023 Lactic Acid Bacteria Biology, Symbioses and Applications GRC
2023年乳酸菌生物学、共生体和应用GRC
- 批准号:
10683583 - 财政年份:2023
- 资助金额:
$ 17.76万 - 项目类别: